Product Reports Resources Pricing Login Book a demo

LIfT BioSciences

Biotech & Life Sciences · London, United Kingdom · Founded 2016

Lift Biosciences is a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy MoreLess

LIfT Biosciences® has a breakthrough allogeneic innate immuno-cell therapy platform called Neutrophil Only Leukocyte Infusion Therapy (N-LIfT®) that allows us to produce different types of Immunomodulatory Alpha Neutrophils (IMAN®s) at scale from iPSCs for a wide range of different purposes as a mono or combo.

Talent graph

LIfT BioSciences's talent

Book a demo to see the people
Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

6 investors on LIfT BioSciences's cap table

Sourced from Dealroom's funding and investor records.

Seed 2 investors entered at this stage
Shadow Foundr
Disruptive Technologies Innovation Fund
Series A 4 investors entered at this stage
Jonathan Milner
LifeSpan Vision Ventures
Starbloom Capital
Sijbrandij Foundation

Global footprint

Where LIfT BioSciences has talent and traffic

Workforce by country
2 countries with
team presence
🇬🇧 United Kingdom73.3%
🇺🇸 United States26.7%
2 countries shown

Market sentiment

What the market is saying about LIfT BioSciences

An AI-synthesized read of the highest-engagement posts about LIfT BioSciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See LIfT BioSciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.